Skip to content

The impact of using different doses of Atorvastatin in patients with STEMI before PCI on the myocardial perfusion and infarction area at first medical contact time

The impact of using different doses of Atorvastatin in patients with STEMI before PCI on the myocardial perfusion and infarction area at first medical contact time

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13003697
Enrollment
Unknown
Registered
2013-10-07
Start date
2013-10-18
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ST-Segment elevation myocardial infarction

Interventions

A:Atorvastatin 80mg
B:Atorvastatin 40mg
C:Atorvastatin 20mg
D:Placebo(Vitamin C 0.2g)

Sponsors

Guangzhou Military Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Men or women aged 18 to 80; 2. Persistent chest pain more than 30 minutes; 3. Electrocardiogram (ecg) of two or more adjacent lead ST segment elevation 0.1mV (0.2mV chest lead); 4. Onset to first medical contact time within 12 hours; 5. No direct PCI contraindications; 6. Agree to accept direct PCI therapy and agreed to participate in clinical research.

Exclusion criteria

Exclusion criteria: Exclusion criteria of preliminary screening: 1. Patients were treated with thrombolytic therapy; 2. Patients with contraindications of coronary angiography and Direct PCI, such as allergy to contrast agents; with hemorrhagic disease or at high risk of bleeding; can't tolerate aspirin and/or clopidogrel and other antiplatelet drugs; with serious infectious diseases; at the end-stage of organic function failure or with advanced cancers and the life expectancy is less than a year; 3. Known allergy to statins or can not tolerate statins; 4. Previous or current treatment with statins; 5. Patients with cardiac shock; 6. Patients who can not take Atorvastatin because of without the placement of stomach tube after cardiopulmonary resuscitation (CPR) or endotracheal intubation; 7. A history of myocardial infarction; 8. Patients who refuse to participate in clinical research. Exclusion criteria after the coronary angiography: 1.Patients are not suitable for the treatment of Direct PCI; 2.Patients and/or the family refuse to Direct PCI because of economic or other reasons.

Design outcomes

Primary

MeasureTime frame
TIMI myocardial perfusion grade(TMPG);

Secondary

MeasureTime frame
SPECT measurement of myocardial infarction area at day 7 after PCI surgery;

Countries

China

Contacts

Public ContactDingcheng Xiang

Guangzhou military hospital

258094875@qq.com+86 13016094355

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026